A new trading day began on Monday, with Axsome Therapeutics Inc (NASDAQ: AXSM) stock price down -4.03% from the previous day of trading, before settling in for the closing price of $178.69. AXSM’s price has ranged from $79.19 to $184.40 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -24.44% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 36.45%. With a float of $41.48 million, this company’s outstanding shares have now reached $50.31 million.
Axsome Therapeutics Inc (AXSM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Axsome Therapeutics Inc is 17.73%, while institutional ownership is 73.87%. The most recent insider transaction that took place on Jan 05 ’26, was worth 13,496,777. Before that another transaction happened on Dec 31 ’25, when Company’s Director sold 37,577 for $165.18, making the entire transaction worth $6,206,969. This insider now owns 10,002 shares in total.
Axsome Therapeutics Inc (AXSM) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -1.54 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Here are Axsome Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.67, a number that is poised to hit -0.73 in the next quarter and is forecasted to reach 0.44 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
Let’s dig in a bit further. During the last 5-days, its volume was 1.32 million. That was better than the volume of 1.24 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 81.51%.
During the past 100 days, Axsome Therapeutics Inc’s (AXSM) raw stochastic average was set at 83.92%, which indicates a significant increase from 67.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 6.33 in the past 14 days, which was higher than the 4.57 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $146.10, while its 200-day Moving Average is $120.19. However, in the short run, Axsome Therapeutics Inc’s stock first resistance to watch stands at $177.48. Second resistance stands at $183.47. The third major resistance level sits at $187.92. If the price goes on to break the first support level at $167.04, it is likely to go to the next support level at $162.59. The third support level lies at $156.60 if the price breaches the second support level.
Axsome Therapeutics Inc (NASDAQ: AXSM) Key Stats
With a market capitalization of 8.65 billion, the company has a total of 50,413K Shares Outstanding. Currently, annual sales are 385,690 K while annual income is -287,220 K. The company’s previous quarter sales were 170,990 K while its latest quarter income was -47,230 K.
